L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II
- PMID: 12850557
- DOI: 10.1016/s0304-3940(03)00579-2
L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II
Abstract
In the present study the effect of endogenous sulphur-containing amino acids, L-cysteine sulphinate, L-cysteate, L-homocysteine sulphinate and L-homocysteate, on the production of glutamate receptor antagonist, kynurenic acid (KYNA), was evaluated. The experiments comprised the measurements of (a). KYNA synthesis in rat cortical slices and (b). the activity of KYNA biosynthetic enzymes, kynurenine aminotransferases (KATs). All studied compounds reduced KYNA production and inhibited the activity of KAT I and/or KAT II, thus acting most probably intracellularly. L-Cysteine sulphinate in very low, micromolar concentrations selectively affected the activity of KAT II, the enzyme catalyzing approximately 75% of KYNA synthesis in the brain. L-Cysteine sulphinate potency was higher than other studied sulphur-containing amino acids, than L-aspartate, L-glutamate, or any other known KAT II inhibitor. Thus, L-cysteine sulphinate might act as a modulator of KYNA formation in the brain.
Similar articles
-
Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.J Neurosci Res. 2005 Feb 1;79(3):375-82. doi: 10.1002/jnr.20359. J Neurosci Res. 2005. PMID: 15605380
-
1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats.Neurosci Lett. 2002 Sep 13;330(1):49-52. doi: 10.1016/s0304-3940(02)00735-8. Neurosci Lett. 2002. PMID: 12213632
-
Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.Eur J Pharmacol. 2016 Oct 15;789:308-312. doi: 10.1016/j.ejphar.2016.07.023. Epub 2016 Jul 14. Eur J Pharmacol. 2016. PMID: 27423316
-
Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration.Pharmacol Rep. 2011;63(6):1324-34. doi: 10.1016/s1734-1140(11)70697-1. Pharmacol Rep. 2011. PMID: 22358081 Review.
-
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.Cell Mol Life Sci. 2010 Feb;67(3):353-68. doi: 10.1007/s00018-009-0166-4. Epub 2009 Oct 15. Cell Mol Life Sci. 2010. PMID: 19826765 Free PMC article. Review.
Cited by
-
Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.J Diabetes Res. 2019 Oct 13;2019:4957879. doi: 10.1155/2019/4957879. eCollection 2019. J Diabetes Res. 2019. PMID: 31737685 Free PMC article.
-
Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.Oxid Med Cell Longev. 2014;2014:646909. doi: 10.1155/2014/646909. Epub 2014 Feb 17. Oxid Med Cell Longev. 2014. PMID: 24693337 Free PMC article. Review.
-
Major Developments in the Design of Inhibitors along the Kynurenine Pathway.Curr Med Chem. 2017;24(23):2471-2495. doi: 10.2174/0929867324666170502123114. Curr Med Chem. 2017. PMID: 28464785 Free PMC article. Review.
-
The Probiotic Lactobacillus reuteri Preferentially Synthesizes Kynurenic Acid from Kynurenine.Int J Mol Sci. 2024 Mar 26;25(7):3679. doi: 10.3390/ijms25073679. Int J Mol Sci. 2024. PMID: 38612489 Free PMC article.
-
Multiple roles of haem in cystathionine β-synthase activity: implications for hemin and other therapies of acute hepatic porphyria.Biosci Rep. 2021 Jul 30;41(7):BSR20210935. doi: 10.1042/BSR20210935. Biosci Rep. 2021. PMID: 34251022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources